Updates on AHPA activities and resources delivered to your inbox. Subscribe today!
In this issue of the IADSA Newsflash: France alerts consumers about food supplements with claims of curing or preventing COVID-19; Israel notifies WTO about revised limits for polyaromatic hydrocarbons (PAHs) in food supplements; Brazil's new resolution mandating a label when food supplements have a new formulation; Ecuador issues rules for cannabis (hemp seed) supplements; and Peru has established a basic regulation governing health claims applicable to supplement products.
AHPA's second, annual Hemp-CBD Supplement Congress was presented on August 27, 2020 and provides companies with an understanding of federal and state legal and regulatory obligations and current issues and opportunities in the hemp-CBD market. This event delivers the latest information to you on-demand.
The September 2020 AHPA Report includes: Inaugural Sports Nutrition Congress; Hemp-CBD Supplement Congress now on-demand; 9th Annual Botanical Congress; AHPA seeks more time for small firms to comply with new labeling rules; Statement on oleandrin; Senator hoping for sensible guidance on CBD; Hemp-CBD market growth; and more.
AHPA presented the inaugural Virtual Sports Nutrition Congress to on Oct. 21 to showcase industry and sports nutrition experts who covered key sport nutrition industry issues by providing the most up-to-date information, resources and practical tools and guidelines to help ensure the long-term success of your business. This event is now available on-demand.
AHPA continues to expand and update the online Botanical Safety Handbook 2nd ed. to provide the herbal industry with comprehensive safety information on over 500 species of herbs from clinical trials, pharmacological and toxicological studies, medical case reports, and historical texts. New safety information has been added to entries on 11 botanicals.
The August 2020 AHPA Report includes: FDA announces resumption of domestic inspections; Daily consumption of certain cranberry products reduces risk of recurrent UTIs; Final guidance on BE labeling; Virtual Hemp-CBD Supplement Congress on Aug. 27; and more.